← All trials
NCT04467918
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2020
- Primary completion
- Nov 16, 2020
- Completion date
- Dec 16, 2020
- First posted
- Jul 13, 2020
- Last posted
- Nov 3, 2020
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Sao PauloLead sponsor
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- University of Sao PauloOverall official - principal investigator
- University of Sao PauloReponsible party - principal investigator
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.